Polar Capital Holdings’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Polar Capital Holdings’s Portfolio RXDX Stock Details RXDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-92,500	Closed	-$9.93M	–	318
2023 Q1	$9.93M	Buy	+92,500	New	+$10.6M	0.06%	190

Other funds holding RXDX

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

FCA

FinTrust Capital Advisors Greenville, South Carolina $591M AUM 26.89% 1-Year Est. Return

Polar Capital Holdings's RXDX Position: Q2 2023 in Review

Polar Capital Holdings sold out of Prometheus Biosciences, Inc. Common Stock (RXDX) in Q2 2023, closing a stake of 92,500 shares — an estimated $9.93M sold.

Polar Capital Holdings first reported a position in RXDX in Q1 2023 and held it in 1 quarter. The position peaked at $9.93M in Q1 2023. 2 funds tracked by Wall St. Rank hold RXDX as of Q2 2023.

Polar Capital Holdings reported no remaining Prometheus Biosciences, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Polar Capital Holdings sold 92,500 Prometheus Biosciences, Inc. Common Stock shares in Q2 2023, an estimated $9.93M.
Polar Capital Holdings first reported a position in Prometheus Biosciences, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
Polar Capital Holdings's Prometheus Biosciences, Inc. Common Stock position peaked at $9.93M in Q1 2023.
2 funds tracked by Wall St. Rank held Prometheus Biosciences, Inc. Common Stock as of Q2 2023.

Based on Polar Capital Holdings's 13F filing for Q2 2023, filed 14 Aug 2023.